Nippon India NIFTY Pharma ETF Growth Plan Performance
Day's Low
Day's High
₹22.86Day's Range₹23.1452 Week's Low
52 Week's High
₹16.5352-Week Range₹24.53
| Returns % | |
| 1 Month Return | + 2.45 % |
| 3 Month Return | -3.93 % |
| 1 Year Return | + 35.7 % |
| Market Stats | |
| Previous Close | ₹22.96 |
| Open | ₹23.11 |
| Upper Circuit | - |
| Lower Circuit | - |
Insights on Nippon India NIFTY Pharma ETF Growth Plan
Insights help you understand the recent movement of the ETF's critical parameters, giving you an overall view of the ETF.
POSITIVE IMPACTPrice Rise
In the last 3 years, Nippon India NIFTY Pharma ETF Growth Plan has moved up by 67.47%
NO EFFECTAgainst Peers
In the last 1 year, Motilal Oswal S&P BSE Healthcare ETF has given 41.87% return, outperforming Nippon India NIFTY Pharma ETF Growth Plan by 6.17%.
- NO EFFECT
Against Peers
In the last 3 year, Aditya Birla Sun Life NIFTY Healthcare ETF has given 72.29% return, outperforming Nippon India NIFTY Pharma ETF Growth Plan by 4.82%.
- NO EFFECT
Market Cap Breakup
Market Cap breakup for Nippon India NIFTY Pharma ETF Growth Plan is 71.52% in LARGE CAP, 19.56% in MID CAP and 8.92% in SMALL CAP with top sector being Pharmaceuticals with 100.00%
ETF Fundamentals
| Expense Ratio | 0.21% |
| Avg. PE ratio | 34.51 |
| Avg. PB ratio | 5.2 |
| AUM | ₹840.57 Cr. |
Companies in Nippon India NIFTY Pharma ETF Growth Plan
| Companies | 1D Returns |
 Sun Pharmaceuticals Industries Ltd | 1.23 |
 Cipla Ltd | 1 |
 Divis Laboratories Ltd | 1.81 |
 Dr Reddys Laboratories Ltd | 0.31 |
 Lupin Ltd | 0.58 |
Portfolio Breakup
Sector
About Nippon India NIFTY Pharma ETF Growth Plan
Owner: Nippon India Mutual Fund
Ticker: PHARMABEES
Price: ₹23.11 per unit as on 26 Dec, 2024 04:01 PM
Asset Under Management AUM: ₹840.57Cr as of today
Expense Ratio: 0.21% as of today
| Exchange | NSE |
| E-voting on shares | Click here to vote |
FAQs on Nippon India NIFTY Pharma ETF Growth Plan
Nippon India NIFTY Pharma ETF Growth Plan price is ₹23.11 today.
- Today’s highest price of Nippon India NIFTY Pharma ETF Growth Plan is ₹23.14
- Today’s lowest price of Nippon India NIFTY Pharma ETF Growth Plan is ₹22.86
| Nippon India NIFTY Pharma ETF Growth Plan | Price |
|---|---|
52 Week High | ₹24.53 |
52 Week Low | ₹16.53 |
| Nippon India NIFTY Pharma ETF Growth Plan | Returns |
|---|---|
1 Day Returns | 0.15% |
1 Month Returns | 2.45% |
3 Month Returns | -3.93% |
1 Year Returns | 35.7% |
Nippon India NIFTY Pharma ETF Growth Plan} price to earning (PE) ratio as on today is 34.51
You can invest via your demat account in the Nippon India NIFTY Pharma ETF Growth Plan. You can invest either through SIP mode or lumpsum mode.
Yes. Nippon India NIFTY Pharma ETF Growth Plan is available for SIP on INDmoney platform for daily, weekly or monthly SIP.
Nippon India NIFTY Pharma ETF Growth Plan's drawbacks are not related to specifically Nippon India NIFTY Pharma ETF Growth Plan. In Indian context, some of the ETFs have a drawbacks of higher tracking, lower trading volumes, etc.
Yes. Nippon India NIFTY Pharma ETF Growth Plan can used as collateral for a loan under Loan Against Securities.